v3.25.4
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 9 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Cash flows from operating activities:    
Net income $ 85,800,000 $ 154,100,000
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 515,600,000 563,100,000
Deferred income taxes (13,300,000) (125,800,000)
Share-based compensation expense related to equity incentive plans 187,100,000 139,700,000
Loss on settlement of debt 0 300,000
Amortization of debt discount 19,600,000 51,600,000
Amortization of debt issuance costs 4,000,000.0 6,100,000
Impairment of intangible assets 2,500,000 0
Other (8,300,000) (45,500,000)
Changes in operating assets and liabilities, excluding impact of acquisitions:    
(Increase) decrease in accounts receivable (40,900,000) 286,500,000
Decrease (increase) in inventories 240,000,000.0 (35,100,000)
Decrease in accounts payable and accrued liabilities (27,400,000) (236,600,000)
Change in other assets and liabilities (92,100,000) (72,700,000)
Change in income tax payable (167,500,000) 6,500,000
Net cash provided by operating activities 705,100,000 692,200,000
Cash flows from investing activities:    
Other investing 1,300,000 2,400,000
Proceeds from capital-related government incentives 5,100,000 100,000
Investments in other assets (72,900,000) (122,500,000)
Capital expenditures (76,900,000) (111,800,000)
Net cash used in investing activities (143,400,000) (231,800,000)
Cash flows from financing activities:    
Repayments of 2025 Term Loan Facility 0 (750,000,000.0)
Proceeds from issuance of Commercial Paper 4,387,500,000 10,567,100,000
Repayments of Commercial Paper (3,460,500,000) (10,630,900,000)
Proceeds from issuance of senior notes 0 1,992,200,000
Repayment of senior notes (1,200,000,000) (1,000,000,000)
Proceeds from issuance of convertible debt 0 1,250,000,000
Payments on settlement of convertible debt 0 (668,500,000)
Deferred financing costs 0 (18,000,000.0)
Purchase of capped call options 0 (105,000,000.0)
Proceeds from sale of common stock 42,500,000 45,400,000
Tax payments related to shares withheld for vested RSUs (29,600,000) (45,000,000.0)
Repurchase of common stock 0 (96,500,000)
Payment of cash dividends on Series A Preferred Stock (80,700,000) 0
Payment of cash dividends on common stock (737,400,000) (730,900,000)
Capital lease payments (1,200,000) (1,200,000)
Other Financing (3,300,000) (2,800,000)
Net cash used in financing activities (1,082,700,000) (194,100,000)
Net (decrease) increase in cash and cash equivalents (521,000,000.0) 266,300,000
Cash and cash equivalents, at beginning of period 771,700,000 319,700,000
Cash and cash equivalents, at end of period $ 250,700,000 $ 586,000,000.0

Source

10-Q PDF XBRL Zip